Compare J.B.Chemicals with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs DIVIS LABORATORIES - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS DIVIS LABORATORIES J.B.CHEMICALS/
DIVIS LABORATORIES
 
P/E (TTM) x 23.1 53.7 43.1% View Chart
P/BV x 4.3 10.6 40.5% View Chart
Dividend Yield % 0.3 0.6 47.6%  

Financials

 J.B.CHEMICALS   DIVIS LABORATORIES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
DIVIS LABORATORIES
Mar-19
J.B.CHEMICALS/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3631,639 22.1%   
Low Rs2551,115 22.9%   
Sales per share (Unadj.) Rs169.1186.3 90.8%  
Earnings per share (Unadj.) Rs16.651.0 32.6%  
Cash flow per share (Unadj.) Rs23.457.3 40.9%  
Dividends per share (Unadj.) Rs2.0016.00 12.5%  
Dividend yield (eoy) %0.61.2 55.7%  
Book value per share (Unadj.) Rs172.5261.8 65.9%  
Shares outstanding (eoy) m83.57265.47 31.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.87.4 24.7%   
Avg P/E ratio x18.627.0 68.9%  
P/CF ratio (eoy) x13.224.0 54.9%  
Price / Book Value ratio x1.85.3 34.1%  
Dividend payout %12.031.4 38.4%   
Avg Mkt Cap Rs m25,827365,592 7.1%   
No. of employees `0003.811.8 31.8%   
Total wages/salary Rs m2,5115,423 46.3%   
Avg. sales/employee Rs Th3,747.44,175.1 89.8%   
Avg. wages/employee Rs Th665.7457.7 145.4%   
Avg. net profit/employee Rs Th367.81,141.8 32.2%   
INCOME DATA
Net Sales Rs m14,13549,463 28.6%  
Other income Rs m3661,556 23.5%   
Total revenues Rs m14,50151,019 28.4%   
Gross profit Rs m2,17818,718 11.6%  
Depreciation Rs m5701,689 33.7%   
Interest Rs m3535 99.7%   
Profit before tax Rs m1,94018,551 10.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5525,023 11.0%   
Profit after tax Rs m1,38713,527 10.3%  
Gross profit margin %15.437.8 40.7%  
Effective tax rate %28.527.1 105.2%   
Net profit margin %9.827.3 35.9%  
BALANCE SHEET DATA
Current assets Rs m10,47046,501 22.5%   
Current liabilities Rs m2,7498,468 32.5%   
Net working cap to sales %54.676.9 71.0%  
Current ratio x3.85.5 69.4%  
Inventory Days Days55131 42.2%  
Debtors Days Days7886 90.5%  
Net fixed assets Rs m5,81125,797 22.5%   
Share capital Rs m167531 31.5%   
"Free" reserves Rs m14,24868,962 20.7%   
Net worth Rs m14,41669,493 20.7%   
Long term debt Rs m00-   
Total assets Rs m17,64980,383 22.0%  
Interest coverage x56.6531.0 10.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 130.2%   
Return on assets %8.116.9 47.8%  
Return on equity %9.619.5 49.4%  
Return on capital %13.726.7 51.2%  
Exports to sales %00-   
Imports to sales %024.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA12,187 0.0%   
Fx inflow Rs m6,16441,238 14.9%   
Fx outflow Rs m1,33412,405 10.8%   
Net fx Rs m4,82928,833 16.8%   
CASH FLOW
From Operations Rs m1,2319,543 12.9%  
From Investments Rs m-208-6,854 3.0%  
From Financial Activity Rs m-595-2,459 24.2%  
Net Cashflow Rs m427230 186.0%  

Share Holding

Indian Promoters % 55.4 52.0 106.5%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 11.8 28.7%  
FIIs % 3.9 19.0 20.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.2 215.1%  
Shareholders   30,437 31,796 95.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  ALEMBIC LTD  ALKEM LABORATORIES  CADILA HEALTHCARE  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (4QFY20); Net Profit Up 35.4% (Quarterly Result Update)

Jun 8, 2020 | Updated on Jun 8, 2020

For the quarter ended March 2020, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (up 35.4% YoY). Sales on the other hand came in at Rs 14 bn (up 9.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (3QFY20); Net Profit Down 4.9% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 4.9% YoY). Sales on the other hand came in at Rs 14 bn (up 3.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 7, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS